Literature DB >> 6403352

Clinical evaluation of free thyroxine calculation from thyroxine and thyroxine binding globulin radioimmunoassays.

Y Shishiba, Y Umezu, N Ohtsuki.   

Abstract

Free T4 calculation was performed based on the equation of the law of mass action between T4 and TBG assessed by routine radioimmunoassay. To examine the validity of this calculation, sera from normal subjects, from hypo- and hyperthyroid patients, from subjects with hereditary deficiency or increase in TBG, and those from uncomplicated pregnancy were included in the assay and the results were compared with those directly measured by radioimmunoassay with encapsulated antibody. Free T4 calculation on the sera described above was almost equal to the free T4 concentration measured directly and reflected clinical thyroid states. Thus, the proposed equation for the calculation of free T4 from total T4 and TBG radioimmunoassay is useful for clinical purposes as well as direct free T4 radioimmunoassay.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6403352     DOI: 10.1007/BF00263504

Source DB:  PubMed          Journal:  Eur J Nucl Med        ISSN: 0340-6997


  10 in total

1.  The ratio of thyroxine to thyroxine-binding globulin in the assessment of thyroid function.

Authors:  W A Burr; S E Evans; J Lee; H P Princé; D B Ramsden
Journal:  Clin Endocrinol (Oxf)       Date:  1979-09       Impact factor: 3.478

2.  ASSESSMENT OF THYROID FUNCTION BY THE COMBINED USE OF THE SERUM PROTEIN-BOUND IODINE AND RESIN UPTAKE OF 131-I-TRIIODOTHYRONINE.

Authors:  F CLARK; D B HORN
Journal:  J Clin Endocrinol Metab       Date:  1965-01       Impact factor: 5.958

3.  Adaptation of the standard Durrum-type cell for reverse-flow paper electrophoresis.

Authors:  K E ELZINGA; E A CARR; W H BEIERWALTES
Journal:  Am J Clin Pathol       Date:  1961-08       Impact factor: 2.493

4.  Correlation of free thyroxine index and thyroxine: thyroxine-binding globulin ratio with the free thyroxine concentration as measured by the thyroxine and thyroxine-binding globulin radioimmunoassays.

Authors:  M Lecureuil; G Crouzat-Reynes; J C Besnard; C Choffel
Journal:  Clin Chim Acta       Date:  1978-08-01       Impact factor: 3.786

5.  Re-evaluation of thyroxine binding and free thyroxine in human serum by paper electrophoresis and equilibrium dialysis, and a new free thyroxine index.

Authors:  S Hamada; T Nakagawa; T Mori; K Torizuka
Journal:  J Clin Endocrinol Metab       Date:  1970-08       Impact factor: 5.958

6.  [Determination of free thyroxine fraction using diluted serum].

Authors:  Y Shishiba; T Shimizu; S Yoshimura; K Shimizu
Journal:  Nihon Naibunpi Gakkai Zasshi       Date:  1970-04-20

7.  Clinical evaluation of new indicators of free thyroxine concentration and thyroxine-binding globulin capacity.

Authors:  S Hamada; T Kosaka; K Torizuka
Journal:  Clin Chim Acta       Date:  1975-09-01       Impact factor: 3.786

8.  Free thyroxine estimates in nonthyroidal illness: comparison of eight methods.

Authors:  E M Kaptein; S S MacIntyre; J M Weiner; C A Spencer; J T Nicoloff
Journal:  J Clin Endocrinol Metab       Date:  1981-06       Impact factor: 5.958

9.  Study of four new kindreds with inherited thyroxine-binding globulin abnormalities. Possible mutations of a single gene locus.

Authors:  S Refetoff; N I Robin; C A Alper
Journal:  J Clin Invest       Date:  1972-04       Impact factor: 14.808

10.  Concentration of thyroxine-binding globulin: value of direct assay.

Authors:  W A Burr; D B Ramsden; S E Evans; T Hogan; R Hoffenberg
Journal:  Br Med J       Date:  1977-02-19
  10 in total
  2 in total

1.  Serum free thyroxine: calculated and measured values.

Authors:  J D Wiener
Journal:  Eur J Nucl Med       Date:  1984

2.  Circulating thyroxine, thyroid-stimulating hormone, and hypothyroid status and the risk of prostate cancer.

Authors:  Alison M Mondul; Stephanie J Weinstein; Tracey Bosworth; Alan T Remaley; Jarmo Virtamo; Demetrius Albanes
Journal:  PLoS One       Date:  2012-10-30       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.